InspireMD, Inc.
NSPR
$2.51
-$0.18-6.69%
| Weiss Ratings | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.61 | |||
| Price History | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.34% | |||
| 30-Day Total Return | -21.32% | |||
| 60-Day Total Return | -7.38% | |||
| 90-Day Total Return | -2.71% | |||
| Year to Date Total Return | -5.64% | |||
| 1-Year Total Return | 9.61% | |||
| 2-Year Total Return | 132.41% | |||
| 3-Year Total Return | -21.07% | |||
| 5-Year Total Return | -72.94% | |||
| 52-Week High % Change | -29.17% | |||
| 52-Week Low % Change | 48.62% | |||
| Price | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.80 | |||
| 52-Week Low Price | $1.81 | |||
| 52-Week Low Price (Date) | Apr 25, 2024 | |||
| 52-Week High Price (Date) | Feb 25, 2025 | |||
| Valuation | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 79.87M | |||
| Enterprise Value | 47.57M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.78 | |||
| Earnings Per Share Growth | -27.94% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 18.77 | |||
| Price/Book (Q) | 1.98 | |||
| Enterprise Value/Revenue (TTM) | 6.79 | |||
| Price | $2.51 | |||
| Enterprise Value/EBITDA (TTM) | -1.43 | |||
| Enterprise Value/EBIT | -1.42 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 48.89M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 776 6804 | |||
| Address | 6303 Waterford District Drive Miami, FL 33126 | |||
| Website | www.inspiremd.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -477.99% | |||
| Profit Margin | -456.62% | |||
| Management Effectiveness | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -44.34% | |||
| Return on Equity | -- | |||
| Income Statement | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 7.01M | |||
| Total Revenue (TTM) | 7.01M | |||
| Revenue Per Share | $0.14 | |||
| Gross Profit (TTM) | 1.51M | |||
| EBITDA (TTM) | -33.22M | |||
| EBIT (TTM) | -33.50M | |||
| Net Income (TTM) | -32.01M | |||
| Net Income Avl. to Common (TTM) | -32.01M | |||
| Total Revenue Growth (Q YOY) | 10.68% | |||
| Earnings Growth (Q YOY) | -69.73% | |||
| EPS Diluted (TTM) | -0.78 | |||
| EPS Diluted Growth (Q YOY) | -16.74% | |||
| Balance Sheet | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 34.64M | |||
| Cash Per Share (Q) | $0.71 | |||
| Total Current Assets (Q) | 40.52M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 36.09M | |||
| Current Ratio (Q) | 5.278 | |||
| Book Value Per Share (Q) | $1.36 | |||
| Total Assets (Q) | 46.81M | |||
| Total Current Liabilities (Q) | 7.68M | |||
| Total Debt (Q) | 2.34M | |||
| Total Liabilities (Q) | 10.72M | |||
| Total Common Equity (Q) | 36.09M | |||
| Cash Flow | NSPR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 12.64M | |||
| Cash from Financing (TTM) | 18.45M | |||
| Net Change in Cash (TTM) | 9.28M | |||
| Levered Free Cash Flow (TTM) | -16.17M | |||
| Cash from Operations (TTM) | -21.87M | |||
